128 related articles for article (PubMed ID: 20404316)
1. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
Rosenow F; Reif PS; Haag A; Schmidt K; Strik H
Neurology; 2010 Apr; 74(16):1330-1; author reply 1331. PubMed ID: 20404316
[No Abstract] [Full Text] [Related]
2. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
Rossetti AO; Stupp R
Neurology; 2010 Apr; 74(16):1329; author reply 1329-30. PubMed ID: 20404315
[No Abstract] [Full Text] [Related]
3. Recurrent glioblastoma: not only surgery.
Xu T; Chen J; Lu Y
J Clin Oncol; 2011 Feb; 29(4):e102; author reply e103. PubMed ID: 21172889
[No Abstract] [Full Text] [Related]
4. Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.
Grunnet ML; O'Neill A; Gilbert M; Hellman R
Clin Neuropathol; 2000; 19(5):230-4. PubMed ID: 11048748
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for glioblastoma: is costly better?
Linz U
Cancer; 2008 Nov; 113(10):2617-22. PubMed ID: 18833584
[No Abstract] [Full Text] [Related]
6. Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
Jaeckle KA; Ballman K; Furth A; Buckner JC
Neurology; 2009 Oct; 73(15):1207-13. PubMed ID: 19822870
[TBL] [Abstract][Full Text] [Related]
7. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
[TBL] [Abstract][Full Text] [Related]
8. Salvage therapy in patients with glioblastoma: is there any benefit?
Hau P; Baumgart U; Pfeifer K; Bock A; Jauch T; Dietrich J; Fabel K; Grauer O; Wismeth C; Klinkhammer-Schalke M; Allgäuer M; Schuierer G; Koch H; Schlaier J; Ulrich W; Brawanski A; Bogdahn U; Steinbrecher A
Cancer; 2003 Dec; 98(12):2678-86. PubMed ID: 14669289
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
10. Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme.
Telfeian AE; Philips MF; Crino PB; Judy KD
J Exp Clin Cancer Res; 2001 Mar; 20(1):5-10. PubMed ID: 11370829
[TBL] [Abstract][Full Text] [Related]
11. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination.
Wheeler CJ; Das A; Liu G; Yu JS; Black KL
Clin Cancer Res; 2004 Aug; 10(16):5316-26. PubMed ID: 15328167
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effect on glioblastoma of chemotherapy on the basis of brain irradiation].
Qin D; Mo H; Ou G
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):168-9. PubMed ID: 11783028
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in adolescents with epilepsy assessed with a measure for adults.
Stevanovic D
Acta Neurol Scand; 2008 Nov; 118(5):343; discussion 343. PubMed ID: 18462477
[No Abstract] [Full Text] [Related]
14. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
Simpson L; Galanis E
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
16. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
17. Epileptic seizures during follow-up of patients treated for primary brain tumors.
Hildebrand J; Lecaille C; Perennes J; Delattre JY
Neurology; 2005 Jul; 65(2):212-5. PubMed ID: 16043788
[TBL] [Abstract][Full Text] [Related]
18. [HIT-GBM: multicenter study of treatment of children with malignant glioma].
Wolff JE; Boos J; Kühl J
Klin Padiatr; 1996; 208(4):193-6. PubMed ID: 8926684
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
20. Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy.
Jeha LE; Najm IM; Bingaman WE; Khandwala F; Widdess-Walsh P; Morris HH; Dinner DS; Nair D; Foldvary-Schaeffer N; Prayson RA; Comair Y; O'Brien R; Bulacio J; Gupta A; Lüders HO
Neurology; 2006 Jun; 66(12):1938-40. PubMed ID: 16801667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
